362 related articles for article (PubMed ID: 10334384)
21. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
Lotz M; Ranheim E; Kipps TJ
J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
[TBL] [Abstract][Full Text] [Related]
23. CD40 stimulation sensitizes CLL cells to rituximab-induced cell death.
Jak M; van Bochove GG; van Lier RA; Eldering E; van Oers MH
Leukemia; 2011 Jun; 25(6):968-78. PubMed ID: 21403646
[TBL] [Abstract][Full Text] [Related]
24. Possible mechanism of action of interferon alpha in chronic B-cell malignancies.
Heslop HE; Brenner MK; Ganeshaguru K; Hoffbrand AV
Br J Haematol; 1991 Oct; 79 Suppl 1():14-6. PubMed ID: 1931702
[TBL] [Abstract][Full Text] [Related]
25. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
26. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
27. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.
Johnson-Léger C; Hasbold J; Holman M; Klaus GG
J Immunol; 1997 Aug; 159(3):1150-9. PubMed ID: 9233608
[TBL] [Abstract][Full Text] [Related]
28. [Preparation of heat shock protein 70 (Hsp70) and idiotypic determinant single-chain antibody (Id-ScFv) in a patient with B-cell chronic lymphatic leukemia (B-CLL) and antitumor effect of peptide complex Hsp70-Id].
Ye Q; Wang ZH; Qin SK
Ai Zheng; 2008 Feb; 27(2):133-8. PubMed ID: 18279608
[TBL] [Abstract][Full Text] [Related]
29. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
Burdin N; Van Kooten C; Galibert L; Abrams JS; Wijdenes J; Banchereau J; Rousset F
J Immunol; 1995 Mar; 154(6):2533-44. PubMed ID: 7533177
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
31. Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia.
Decker T; Flohr T; Trautmann P; Aman MJ; Holter W; Majdic O; Huber C; Peschel C
Blood; 1995 Aug; 86(3):1115-23. PubMed ID: 7620165
[TBL] [Abstract][Full Text] [Related]
32. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
33. Effect of alemtuzumab on neoplastic B cells.
Golay J; Manganini M; Rambaldi A; Introna M
Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398
[TBL] [Abstract][Full Text] [Related]
34. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
35. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
36. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
[TBL] [Abstract][Full Text] [Related]
37. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia.
Berrebi A; Shtalrid M; Klepfish A; Bassous L; Kushnir M; Shulman L; Vorst E; Hahn T
Leukemia; 1994 Dec; 8(12):2214-6. PubMed ID: 7808009
[TBL] [Abstract][Full Text] [Related]
38. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
[TBL] [Abstract][Full Text] [Related]
39. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
40. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen.
Garrone P; Galibert L; Rousset F; Fu SM; Banchereau J
J Immunol; 1994 May; 152(9):4282-90. PubMed ID: 7512590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
